'Female Viagra' Submitted to the FDA for a 3rd Attempt

The controversial drug developed to treat hypoactive sexual desire disorder has been rejected twice for inconclusive effectiveness.
1:14 | 06/04/15

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

Comments
Related Extras
Related Videos
Video Transcript
Transcript for 'Female Viagra' Submitted to the FDA for a 3rd Attempt
We turn to an important hurdle for the so-called viagra for women. A key fda advisory committee holes a hearing and a green light from them could lead to it going on sale and ABC's kayna Whitworth has the story. Reporter: This morning hanging in the balance the female version of viagra. A controversial drug going to the fda advisory committee for the third time later today. Its real name is the less than sexy flibanseral. Treating hypoactive sexual desire disorder. Affecting an estimated 1 in 10 women. Two attempts at bringing it to market have failed in 2010 and 013 given what experts described as inconclusive advantages when comparedplacebo. It's aimed at premenopausal women can have significant side effects including nausea, dizziness and sleepiness. The CEO of the pharmaceutical company says the third time is a charm and addressed the fda's larger concerns about the pill's it's action with other drugs, also according to fda documents from a previous study, women using this drug reported more sexually satisfying experiences.

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"1:14","description":"The controversial drug developed to treat hypoactive sexual desire disorder has been rejected twice for inconclusive effectiveness.","mediaType":"default","section":"ABCNews/GMA","id":"31520490","title":"'Female Viagra' Submitted to the FDA for a 3rd Attempt","url":"/GMA/video/female-viagra-submitted-fda-3rd-attempt-31520490"}